Morning Overview on MSN
Engineered bacteria deliver chemo drug inside tumors in mice
Researchers at the National University of Singapore have engineered a common gut bacterium to carry a chemotherapy prodrug ...
Subcutaneous nivolumab and hyaluronidase-nvhy is FDA-approved for adult solid tumors, offering a new administration route for PD-1 inhibitors. The phase 3 CheckMate-67T trial confirmed noninferiority ...
The question is not just substitution but how SC therapeutics integration will affect health care delivery at scale. The real question is can we afford to ignore a more efficient, patient-centered ...
Dr. Eric K. Singhi discusses the benefit of subcutaneous immunotherapy following the FDA approval of subcutaneous Opdivo for patients with solid tumors. On Dec. 27, 2024, the Food and Drug ...
The US FDA has approved pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex, Merck), a subcutaneous version of the intravenous formulation of Keytruda, for adults and children aged 12 years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results